פרק 8: האם התרופות הממריצות יעילות בטווח הקצר?

רשימת מקורות

1. CHADD. Managing Medication. CHADD:  Children and Adults with ADHD , 4221 Forbes Blvd, Suite 270, Lanham, MD, 20706. Last retrieved on November 16, 2021 from: https://chadd.org/for-parents/managing-medication/; Retreived on November 2021.
2. National Institute for Health and Care Excellence. Attention deficit hyperactivity disorder (update)  [C] Evidence reviews for pharmacological efficacy and sequencing pharmacological treatment  Last retrieved on August 20, 2021 from:  https://www.nice.org.uk/guidance/ng87/evidence/c-pharmacological-efficacy-and-sequencing-pdf-4783686303; 2018.
3. Kooij JJS, Bijlenga D, Salerno L, et al. Updated European Consensus Statement on diagnosis and treatment of adult ADHD. European psychiatry. 2019;56:14-34.
4. Cortese S. Pharmacologic treatment of attention deficit–hyperactivity disorder. New England Journal of Medicine. 2020;383(11):1050-1056.
5. Storebø OJ, Krogh HB, Ramstad E, et al. Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials. Bmj. 2015;351
6. Cortese S, Adamo N, Del Giovane C, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. The Lancet Psychiatry. 2018;5(9):727-738.
7. National Institute for Health and Care Excellence. Attention deficit hyperactivity disorder (update)  [C] Evidence reviews for pharmacological efficacy and sequencing pharmacological treatment. Last retrieved on August 20, 2021 from:  https://www.nice.org.uk/guidance/ng87/evidence/c-pharmacological-efficacy-and-sequencing-pdf-4783686303; 2018.
8. Howick J. Exploring the asymmetrical relationship between the power of finance bias and evidence. Perspectives in biology and medicine. 2019;62(1):159-187.
9. Eisenberg L. Commentary with a historical perspective by a child psychiatrist: when "ADHD" was the "brain-damaged child". 2007;(1044-5463 (Print))
10. Ophir Y. Evidence that the Diagnosis of ADHD Does Not Reflect a Chronic Bio-Medical Disease. Ethical Human Psychology and Psychiatry. 2022;23-2
11. Bowman E, Coghill D, Murawski C, Bossaerts P. Not so smart? “Smart” drugs increase the level but decrease the quality of cognitive effort. Science Advances. 2023;9(24):eadd4165. doi:10.1126/sciadv.add4165
12. Barkley RA, Cunningham CE. Do stimulant drugs improve the academic performance of hyperkinetic children? A review of outcome studies. Clinical Pediatrics. 1978;17(1):85-92.
13. Barkley RA, Cunningham CE. The effects of methylphenidate on the mother-child interactions of hyperactive children. Archives of General Psychiatry. 1979;36(2):201-208.
14. Wolraich ML, Doffing MA. Pharmacokinetic Considerations in the Treatment of Attention-Deficit Hyperactivity Disorder with Methylphenidate. CNS Drugs. 2004/04/01 2004;18(4):243-250. doi:10.2165/00023210-200418040-00004
15. Netflix. Take Your Pills. Netflix, Inc. US. ; 2018.
16. Smith ME, Farah MJ. Are prescription stimulants “smart pills”? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychological bulletin. 2011;137(5):717.
17. Ilieva IP, Hook CJ, Farah MJ. Prescription stimulants' effects on healthy inhibitory control, working memory, and episodic memory: a meta-analysis. Journal of cognitive neuroscience. 2015;27(6):1069-1089.
18. Farah MJ. The unknowns of cognitive enhancement. Science. 2015;350(6259):379-380.
19. Rotem A, Ben-Sheetrit J, Newcorn J, et al. The Placebo Response in Adult ADHD as Objectively Assessed by the TOVA Continuous Performance Test. Journal of Attention Disorders. 2020:1087054719897819. doi:10.1177/1087054719897819
20. Ben-Sheetrit J, Peskin M, Newcorn JH, et al. Characterizing the Placebo Response in Adults With ADHD. Journal of Attention Disorders. 2020/02/01 2020;24(3):425-433. doi:10.1177/1087054718780328
21. Burke MJ. A fundamental change is needed for appraising placebo responses in psychiatry. The Lancet Psychiatry. 2023;10(5):316-317. doi:10.1016/S2215-0366(23)00068-8
22. Doidge N. The brain that changes itself: Stories of personal triumph from the frontiers of brain science. Penguin; 2007.
23. Rubin BP. Changing brains: The emergence of the field of adult neurogenesis. BioSocieties. 2009;4(4):407-424.
24. Jensen PS, Arnold LE, Swanson JM, et al. 3-year follow-up of the NIMH MTA study. Journal of the American Academy of Child & Adolescent Psychiatry. 2007;46(8):989-1002.
25. Elliott J, Johnston A, Husereau D, et al. Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis. PLoS One. 2020;15(10):e0240584.

בחזרה לעמוד הראשי של רשימת המקורות של הספר, לחצו כאן.